hers glp-1 Digital pharmacy to offer weight-loss drug cheaper than Ozempic Weight Loss Medication | Take
Description
Additionally, lixisenatide was associated with fewer gastrointestinal symptoms compared to exenatide, while long-acting GLP-1RAs generally caused less nausea and vomiting but more diarrhea than short-acting agents (49)
Gorbea E, Kidwai S, Rosenberg J
CBC also noted that Canada is the only country where Novo Nordisk allowed the patent for its semaglutide drugs to expire, with regulatory exclusivity ending January 4 [Source: cbc.ca/news/health/ozempic-glp1-health-canada-generic-9.7034498]
What matters now is how systems, insurers, and practices adapt, not just whether the drugs work
